Iniciar Sesión Regístrate abrir menu

Bibliografía Científica

Artículos por temáticas

En este apartado encontrará una actualización mensual de Enfermedad de Alzheimer y Demencias

8059 ARTÍCULOS , VIENDO DEL 7951 AL 7965

The role of exosomes in diagnosis, pathophysiology, and management of Alzheimer's Disease

Daksh R, Mathew MS, Bosco AM, Sojan C, Tom AA, Bojja SL, Nampoothiri M.

Biochem Biophys Res Commun. 2025 Mar 25;754:151526. doi: 10.1016/j.bbrc.2025.151526. Epub 2025 Feb 21.

From Better Diagnostics to Earlier Treatment: The Rapidly Evolving Alzheimer's Disease Landscape

Bougea A, Debasa-Mouce M, Gulkarov S, Castro-Mosquera M, Reiss AB, Ouro A.

Medicina (Kaunas). 2025 Aug 14;61(8):1462. doi: 10.3390/medicina61081462.

Defining benefit: Clinically and biologically meaningful outcomes in the next-generation Alzheimer's disease clinical care pathway

Elhage A, Cohen S, Cummings J, van der Flier WM, Aisen P, Cho M, Bell J, Hampel H.

Alzheimers Dement. 2025 Feb;21(2):e14425. doi: 10.1002/alz.14425. Epub 2024 Dec 19.

Elevated D-dimer levels after lecanemab infusions: a case report

Zou M, Xu SS, Zhu SG, Yuan CX, Huang JF, Zhu JH, Zhang X, Wang JY.

BMC Geriatr. 2025 Sep 29;25(1):742. doi: 10.1186/s12877-025-06445-z.

Next-generation biosensor technologies for Alzheimer's disease: Innovations in diagnosis, monitoring, and treatment

Yin C, Tang X, Zeng J, Wang Z, Mi J, Liang Y, Qin D, Feng Q, Wu A.

Ageing Res Rev. 2026 Jan;114:102954. doi: 10.1016/j.arr.2025.102954. Epub 2025 Nov 19.

Genetically determined Alzheimer's disease research advances: The Down Syndrome & Autosomal Dominant Alzheimer's Disease 2024 Conference

Falgàs N, Maure-Blesa L, Ances B, Flores-Aguilar L, Hartley S, Hassenstab J, Iulita MF, Janicki M, Koenig K, Lao P, Levin J, McDade E, Meijer L, Rafii MS, Snyder HM, Sánchez-Valle R, Fortea J; DSAD‐ADAD conference group; Arriola Infante J, Balasa M, Barroeta I, Barthelemy R N, Bejanin A, Benejam B, Bosch B, Bradshaw A, Carmona-Iragui M, Cohen A, Comas Albertí A, Csincsik L, Cuello AC, Del Hoyo Soriano L, Dijkstra J, Edwards N, Giménez S, Gonzalez-Ortiz F, Gordon B, Gutiérrez Fernández S, Handen B, Jacob C, Johnson E, Johansson C, Lladó A, Lleó A, Morabito S, Morcillo-Nieto AO, Montoliu-Gaya L, Okafor M, Pérez-Millan A, Potier MC, Ringman J, Rodríguez-Baz Í, Rubenstein E, Ryan NS, Strydom A, Vaqué-Alcázar L, Vermunt L, Videla Toro L, Zaman S.

Alzheimers Dement. 2025 Jul;21(7):e70309. doi: 10.1002/alz.70309.

Randomized phase 2a trial assessing a novel septin molecular glue in Alzheimer's disease

Nuytten M, Voets M, Debroux E, Princen K, Pringels L, Fivaz M, Byl E, Ramael S, De Witte K, Boada M, Morató X, Tartari JP, Lafuente A, Macias EF, Matias-Guiu JA, Vijverberg E, Teunissen CE, Anderer P, Staggs V, Hayman V, Corbett A, Ballard C, Harrison JE, Windisch M, Westman AB, Zetterberg H, Dickson S, Mallinckrodt C, Hendrix S, Cummings J, Griffioen G.

Alzheimers Dement. 2025 Sep;21(9):e70537. doi: 10.1002/alz.70537.

Diagnosis of Alzheimer's disease: Recommendations from the French Federation of Memory Clinics

Dumurgier J, Défontaines B, Gallouj K, Garcin B, Garnier-Crussard A, Lagarde J, Pauly JM, Rollin Sillaire A, Rouch-Leroyer I, Sarazin M, Verny M, Wallon D.

Rev Neurol (Paris). 2025 Dec;181(10):1021-1029. doi: 10.1016/j.neurol.2025.09.004. Epub 2025 Sep 30.

Quantum dots in neurotheranostics for the treatment of Alzheimer's disease

Sharma T, Bashir B, Sharma P, Andotra N, Singh SK, Singh TG, Vishwas S.

Ageing Res Rev. 2025 Dec;112:102876. doi: 10.1016/j.arr.2025.102876. Epub 2025 Aug 20.

Pharmacokinetic and pharmacodynamic assessment of oral nicotinamide in the NEAT clinical trial for early Alzheimer's disease

Ketron GL, Grun F, Grill JD, Feldman HH, Rissman RA, Brewer GJ.

Alzheimers Res Ther. 2025 Mar 11;17(1):59. doi: 10.1186/s13195-025-01693-y.

MicroRNA-based recent research developments in Alzheimer's disease

Ramirez-Gomez J, Dalal S, Devara D, Sharma B, Rodarte D, Kumar S.

J Alzheimers Dis. 2025 Mar;104(1):14-31. doi: 10.1177/13872877241313397. Epub 2025 Feb 2.

Evaluating Plasma p-tau217 as an Endpoint for Alzheimer Disease Clinical Trials

Ferreira PCL, Bellaver B, Povala G, Bauer-Negrini G, Aguzzoli CS, Ferrari-Souza JP, Leffa DT, Soares C, Lussier FZ, Medeiros MS, Felix C, Ruppert E, Rohden F, Borelli WV, Karim HT, Langhough R, Christian BT, Wilson R, Hong CH, Roh HW, Patira R, Tudorascu DL, Zimmer ER, Betthauser TJ, Karikari TK, Snitz BE, Johnson SC, Son SJ, Pascoal TA.

Neurology. 2026 Jan 13;106(1):e214441. doi: 10.1212/WNL.0000000000214441. Epub 2025 Dec 9.

Tailoring the biomarkers of Alzheimer's disease using a gut microbiome-centric approach: Preclinical, clinical, and regulatory perspectives

Sharma S, Bashir B, Kolekar KA, Acharya A, Gupta M, Jena R, Vishwas S, Kaur J, Gupta G, Kumbhar PS, Patle D, Chaitanya M, Gulati M, Singh SK.

Ageing Res Rev. 2025 Dec;112:102888. doi: 10.1016/j.arr.2025.102888. Epub 2025 Sep 1.

The Diagnostic and Therapeutic Potential of Oligonucleotide Aptamers in Alzheimer's Disease

Katsipis G, Tzekaki EE, Iasonidou S, Pantazaki AA.

Cells. 2025 Sep 11;14(18):1424. doi: 10.3390/cells14181424.

Therapeutic Potential for Cannabidiol on Alzheimer's Disease-Related Neuroinflammation: A Systematic Review and Meta-Analysis

Wu S, Rajiah T, Ali AB.

Int J Mol Sci. 2025 Dec 11;26(24):11963. doi: 10.3390/ijms262411963.

Actualización mensual Regístrese para recibir los avisos de actualización

Si quiere recomendar un artículo/publicación para completar este apartado puede hacerlo a través del formulario de contacto para su valoración.

En ningún caso la información facilitada constituye asesoramiento por parte de Zambon

Con el aval de:

Logo SEN Logo WIS

En colaboración con:

Zambon Neurociencias